Saudi Arabian Metal Fabrication Equipment Market Saudi Arabian Metal Fabrication Equipment Market Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Saudi Arabia Metal Fabrication Equipment Market, By Region, Competition, Forecast & Opportunities, 2019-2029F" report has been added to ResearchAndMarkets.com's offering.The Saudi Arabia Metal Fabrication Equipment Market was valued at USD 2.07 Billion in 2023, and is expected to reach USD 2.81 Billion by 2029, rising at a CAGR of 5.10%. The Metal Fabrication ...

Global Transfection Reagents & Equipment Market Global Transfection Reagents & Equipment Market Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Transfection Reagents & Equipment Market by Product, by Method, by Application, by End-User, and By Region" report has been added to ResearchAndMarkets.com's offering.The global transfection reagents & equipment market size was estimated to be USD 1.47 billion in 2023 and is expected to reach USD 3.34 billion by 2034 with a CAGR of 7.78% during the forecast peri ...

Blagnac, France, January 09th 2025-5.35 pm Yearly Statement H2 2024 relative to the liquidity contract placed with Societe de bourse Gilbert Dupont In respect of the liquidity contract placed by SOGECLAIR with Société de Bourse Gilbert Dupont, as of 31 December 2024, the average liquidity account figures stood at: Number of shares: 1 872Cash balance: €24,521.23 During the 2nd half 2024, it has been trade a total of: PURCHASE18 053 equities€364,232.95643 equitiesSALE18 472 equities€370,623.45680 equities Y ...

Phase 3 ABTECT Trial Progress - The Phase 3 ABTECT trial evaluating obefazimod for moderately to severely active ulcerative colitis (UC) has enrolled 1,003 participants, representing 82% of the targeted 1,224 participants [2][5][6] - Enrollment completion is expected in Q2 2025, with top-line results for the 8-week induction trial anticipated in Q3 2025 [2][5][6] - The 44-week maintenance data is on track for Q2 2026, and if successful, an NDA submission is planned for H2 2026 [5][6] Company Strategy and Financial Position - The company's cash runway extends beyond the expected top-line results from the ABTECT induction trial and into Q4 2025, without the need for additional financing [4][5] - The company believes 2025 will be a pivotal year, with key data readouts and the advancement of its broader portfolio addressing chronic inflammatory conditions [3] Participant and Safety Data - Blinded baseline characteristics of participants align with the pre-specified target population and are consistent with the Phase 2b UC trial [5][6] - No new safety signals have been observed to date, with oversight from the independent Data Monitoring Committee [6] Company Overview - Abivax is a clinical-stage biotechnology company focused on developing therapeutics for chronic inflammatory diseases, with its lead drug candidate, obefazimod (ABX464), in Phase 3 clinical trials for UC [7]

Saudi Arabian Reinforced Thermoplastic Pipes Market Saudi Arabian Reinforced Thermoplastic Pipes Market Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Saudi Arabia Reinforced Thermoplastic Pipes Market, By Region, Competition, Forecast & Opportunities, 2019-2029F" report has been added to ResearchAndMarkets.com's offering.The Saudi Arabia Reinforced Thermoplastic Pipes Market was valued at USD 263.27 Million in 2023, and is expected to reach USD 349.12 Million by 2029, rising at a CAGR of 4.66%The Rein ...

Imagine having top real estate agents not only bidding for your listing but also showcasing their unique expertise, marketing strategies, and added perks—all designed to give you the best possible selling experience. With Hyyve, sellers are in control, choosing the agent who offers the highest value and best fit, all through a streamlined, transparent process. TORONTO, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Hyyve, a revolutionary Canadian marketplace that enables homeowners to receive upfront payments fo ...

This Genomic Biomarkers market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. Genomic Biomarkers Market Genomic Biomarkers Market Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Genomic Biomarkers Market Report 2024" has been added to ResearchAndMarkets.com's offering.The genomic biomarkers market size ...

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Lead Smelting and Refining Market size & share revenue was valued at approximately USD 22.30 Billion in 2023 and is expected to reach USD 23.59 Billion in 2024 and is expected to reach around USD 36.50 Billion by 2033, at a CAGR of 4.97% between 2024 and 2033. The key market players listed in the report with their sales, revenues and strategies are Nyrstar NV, Hindustan Zinc Lim ...

Boston, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Expert Consumers has named QuickBooks Payroll as a top payroll service for businesses in 2025. This recognition is due to the platform’s robust features, streamlined functionality, and exceptional support designed to simplify payroll management and enhance efficiency. Top Payroll Software QuickBooks - a comprehensive financial software platform offering accounting, payroll, tax, and business management solutions to streamline operations for small and midsize busine ...

Passenger Cars Cybersecurity Market Passenger Cars Cybersecurity Market Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Passenger Cars Cybersecurity Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ResearchAndMarkets.com's offering.The Passenger Cars Cybersecurity Market was valued at USD 2.86 Billion in 2023, and is expected to reach USD 4.12 Billion by 2029, rising at a CAGR of 6.33% The global passenger cars cybersecurity market is experien ...